Product news

Share this article:
The FDA has approved AstraZeneca's Seroquel (quetiapine fumarate tablets) for the maintenance treatment of patients with bipolar I disorder, as adjunct therapy to lithium or divalproex. Seroquel is already indicated for the treatment of schizophrenia, depressive episodes in bipolar disorder and acute mania in bipolar I disorder.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions